Authors
Loading...
Preclinical study reveals cooperative oncogenic mechanisms in advanced thyroid cancer models, highlighting therapeutic vulnerabilities to mTOR, MEK, and BRD4 inhibitors.
Krishnamoorthy et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: